Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Tellurium Compound AS101 Ameliorates Experimental Autoimmune Encephalomyelitis by VLA-4 Inhibition and Suppression of Monocyte and T Cell Infiltration into the CNS.
Validation of Social Media Analysis for Outcomes Research: Identification of Drivers of Switches between oral and Injectable Therapies for Multiple Sclerosis.
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.
Laquinimod therapy in multiple sclerosis: a comprehensive review.
Uptake of environmental toxicants by the locus ceruleus: A potential trigger for neurodegenerative, demyelinating and psychiatric disorders.
The Case | The young philosopher with multiple sclerosis and proteinuria.
Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index.
Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Deep brain stimulation for pain.
Multiple sclerosis: overview of disease-modifying agents.
The Plant-Derived Chalcone 2,2',5'-Trihydroxychalcone Provides Neuroprotection against Toll-Like Receptor 4 Triggered Inflammation in Microglia.
Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
Prospects of Cinnamon in Multiple Sclerosis.
Do patient and proxy agree? Long-term changes in multiple sclerosis physical impact and walking ability on patient-reported outcome scales.
Attention-related changes in short-term cortical plasticity help to explain fatigue in multiple sclerosis.
Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography.
The Correlation between Aquaporin-4 Antibody and the Visual Function of Patients with Demyelinating Optic Neuritis at Onset.
Physiological Dynamics in Demyelinating Diseases: Unraveling Complex Relationships through Computer Modeling.
Assessment of Autonomic Dysfunction in Childhood Guillain-Barré Syndrome.
Characterization of a eukaryotic-like protein kinase, DspB, with an atypical catalytic loop motif from Myxococcus xanthus.
The putative acceleration of optic neuritis when combined with chronic hepatitis B.
Repeatability of quantitative sodium magnetic resonance imaging for estimating pseudo-intracellular sodium concentration and pseudo-extracellular volume fraction in brain at 3 T.
The Stress-Buffering Effects of Hope on Adjustment to Multiple Sclerosis.
Multiparity in women with multiple sclerosis causes less long-term disability: Commentary.
Medical image. Neuromyelitis optica masquerading as sepsis.
Pages
« first
‹ previous
…
646
647
648
649
650
651
652
653
654
…
next ›
last »